BackAmicus Therapeutics Overview

Amicus Therapeutics Cost of Revenue

Cost of Revenue analysis for FOLD.

Quarterly Cost of Revenue

$24.67M
↑ 134.98% YoY

As of Dec 31, 2025

Annual Cost of Revenue (TTM)

$72.93M
↑ 50.04% YoY

Trailing 12 months ending Dec 31, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin